Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Quetiapine may cause hair loss.

Hair loss after weight loss surgery can improve over time.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

Taking zinc sulphate stopped and reversed hair loss in patients after weight loss surgery.

COVID-19 can cause hair loss starting as early as 18 days after infection.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

Telogen effluvium is a condition that causes temporary hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases without surgery.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.